Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
What ipsilateral lung constraints if any do you utilize for SBRT and or hypofractionated RT in the lungs?
Do you consider mean ipsilateral lung dose?
Related Questions
How does metaplastic thymoma histology impact your decision regarding adjuvant radiation?
Would you give lung SBRT to a patient with bullous pemphigoid on the chest and torso?
how do you manage atypical adenomatous hyperplasia (AAH) at the margin for 2 sites of the same lobe, in a patient with multiple GGO's s/p wedge resection?
How do you approach a patient with stage IIA non-small cell lung cancer who received SBRT?
Do you have different hotspot and heterogeneity goals for SBRT of ground glass lesions vs more solid adenocarcinoma NSCLC lesions?
What is your approach to adjuvant RT or chemoRT in LS-SCLC s/p lobectomy with N1 disease?
What is the role of consolidative durvalumab and prophylactic cranial irradiation in patients with stage I small cell lung cancer?
How would you post-operatively manage a peripheral stage I small cell lung carcinoma s/p upfront wedge resection with an R1 microscopic positive margin along the staple line and visceral pleural invasion?
How are you incorporating Tumor Treating Fields for locally progressive/metastatic NSCLC, if at all?
How do you assess whether a patient will be a good DIBH candidate for lung or abdomen treatments?